Bio-Works Technologies AB (ST:BIOWKS) — Stock Price
Bio-Works Technologies AB (ST:BIOWKS) is currently trading at Skr3.20 SEK, down 1.84% today. Over the past 52 weeks, shares have ranged between Skr2.21 and Skr4.68. This page tracks Bio-Works Technologies AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BIOWKS company net worth.
Bio-Works Technologies AB (BIOWKS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bio-Works Technologies AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bio-Works Technologies AB Income Statement — Revenue, Profit & Earnings by Year
Bio-Works Technologies AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Skr62.50 Million | Skr25.46 Million | Skr43.90 Million | Skr41.32 Million | Skr21.91 Million |
| Cost of Revenue | Skr14.70 Million | Skr5.45 Million | Skr17.07 Million | Skr12.47 Million | Skr3.35 Million |
| Gross Profit | Skr47.80 Million | Skr20.02 Million | Skr26.82 Million | Skr28.85 Million | Skr18.56 Million |
| Research & Development | — | — | — | — | Skr232.00K |
| SG&A | — | — | — | — | Skr28.35 Million |
| Total Operating Expenses | Skr65.32 Million | Skr58.01 Million | Skr83.17 Million | Skr75.99 Million | Skr29.52 Million |
| Operating Income | Skr-17.52 Million | Skr-38.00 Million | Skr-55.42 Million | Skr-47.14 Million | Skr-10.96 Million |
| EBITDA | Skr-16.46 Million | Skr-36.76 Million | Skr-54.12 Million | Skr-46.10 Million | Skr-8.88 Million |
| EBIT | Skr-16.97 Million | Skr-37.27 Million | Skr-54.73 Million | Skr-46.57 Million | Skr-9.35 Million |
| Interest Expense | Skr193.00K | Skr9.00K | Skr3.00K | Skr23.00K | Skr18.00K |
| Income Before Tax | Skr-17.16 Million | Skr-37.28 Million | Skr-54.73 Million | Skr-44.70 Million | Skr-9.37 Million |
| Income Tax Expense | Skr-1.92 Million | Skr76.00K | Skr2.09 Million | Skr255.00K | Skr3.57 Million |
| Net Income | Skr-15.25 Million | Skr-37.36 Million | Skr-56.82 Million | Skr-44.95 Million | Skr-12.94 Million |
Bio-Works Technologies AB Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bio-Works Technologies AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Skr70.76 Million | Skr52.50 Million | Skr62.15 Million | Skr91.61 Million | Skr120.86 Million |
| Total Current Assets | Skr69.05 Million | Skr50.68 Million | Skr59.66 Million | Skr89.18 Million | Skr119.08 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Skr18.47 Million | Skr4.84 Million | Skr9.15 Million | Skr11.88 Million | Skr6.84 Million |
| Inventory | Skr15.64 Million | Skr10.06 Million | Skr9.07 Million | Skr9.67 Million | Skr7.85 Million |
| Property, Plant & Equipment | — | — | — | Skr2.43 Million | Skr1.78 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Skr21.55 Million | Skr7.91 Million | Skr18.12 Million | Skr23.92 Million | Skr12.35 Million |
| Total Current Liabilities | Skr21.55 Million | Skr7.91 Million | Skr18.12 Million | Skr23.92 Million | Skr12.35 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Skr-34.93 Million | Skr-34.28 Million | Skr-39.38 Million | Skr-65.88 Million | Skr-102.75 Million |
| Total Stockholder Equity | Skr49.21 Million | Skr44.58 Million | Skr44.03 Million | Skr67.69 Million | Skr108.51 Million |
| Retained Earnings | Skr-358.42 Million | Skr-342.96 Million | Skr-305.76 Million | Skr-248.84 Million | Skr-203.98 Million |
Bio-Works Technologies AB Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bio-Works Technologies AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Skr-18.81 Million | Skr-43.17 Million | Skr-58.99 Million | Skr-39.88 Million | Skr-13.37 Million |
| Capital Expenditures | Skr404.00K | Skr8.00K | Skr860.00K | Skr1.12 Million | Skr942.00K |
| Free Cash Flow | Skr-19.21 Million | Skr-43.18 Million | Skr-59.85 Million | Skr-41.00 Million | Skr-14.31 Million |
| Investing Cash Flow | Skr-404.00K | Skr158.00K | Skr-860.00K | Skr-1.12 Million | Skr-942.00K |
| Financing Cash Flow | Skr20.08 Million | Skr37.75 Million | Skr33.26 Million | Skr4.04 Million | Skr83.96 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Skr512.00K | Skr514.00K | Skr611.00K | Skr475.00K | Skr757.00K |
| Change in Cash | Skr653.00K | Skr-5.10 Million | Skr-26.49 Million | Skr-36.87 Million | Skr69.69 Million |
Bio-Works Technologies AB Earnings History — EPS Actual vs. Analyst Estimates
Track Bio-Works Technologies AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 15, 2025 | — | — | — |
| Feb 21, 2025 | — | — | — |
| Feb 19, 2021 | -0.79 | — | — |
| Aug 21, 2020 | -0.32 | — | — |
| Apr 24, 2020 | -0.37 | — | — |
| Feb 14, 2020 | -0.36 | — | — |
| Sep 30, 2019 | -0.38 | — | — |
| Aug 23, 2019 | -0.46 | — | — |